Bullish on Bristol Myers Squibb
Update 9/27/2024: Cobenfy (formerly KarXT) was Approved by the FDA. 1st Schizophrenia drug in a long time, and the 1st that doesn’t block Dopamine. Which is a common reason people … Read More
Update 9/27/2024: Cobenfy (formerly KarXT) was Approved by the FDA. 1st Schizophrenia drug in a long time, and the 1st that doesn’t block Dopamine. Which is a common reason people … Read More
Nvidia’s fall from grace has been nothing short of epic, with a loss of 20+ points since earnings. Then dropping almost 10% today amongst a sea of red. There is … Read More
Massive Sell Off So why the massive sell off? Have people just gotten tired of intel’s slow movement and constant retractions? Not exactly, while that could be annoying for anything … Read More
Sell Off What a wild day we had. The day before we Federal Reserve Chair Jerome Powell speak on the decision to hold interest rates steady. Then today the Dow … Read More
GSK’s Jemperli: Awaitng FDA Decision on Expanding Treatment Options. GlaxoSmithKline (GSK)’s immunotherapy drug, Jemperli, is currently under review by the FDA for potential approval in additional cancer indications. The drug … Read More
Cold Storage Giant’s IPO Lineage Logistics, a behemoth in the cold storage and logistics sector, is set to make a significant entrance into the public market through its Initial Public … Read More
Tech Stocks Slide Dragging Market Tech stocks took a significant hit on Wednesday, dragging the broader market lower. Disappointing earnings reports from tech giants like Tesla and Alphabet sent shockwaves … Read More
Bitcoin has finally broken through the long-standing resistance level of $60,000. Previously, the cryptocurrency would repeatedly plummet whenever it approached this price point due to massive sell-offs. What is Bitcoin? … Read More